Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.32 - $15.6 $28,960 - $1.41 Million
-90,500 Reduced 74.98%
30,200 $9,000
Q1 2022

May 16, 2022

SELL
$0.86 - $1.86 $3,956 - $8,556
-4,600 Reduced 3.67%
120,700 $142,000
Q4 2021

Feb 14, 2022

BUY
$1.64 - $3.13 $49,528 - $94,526
30,200 Added 31.76%
125,300 $205,000
Q3 2021

Nov 15, 2021

BUY
$2.67 - $5.09 $253,917 - $484,059
95,100 New
95,100 $274,000

About ReShape Lifesciences Inc.


  • Ticker RSLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,559,400
  • Market Cap $118M
  • Description
  • ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...
More about RSLS
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.